Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe

Published: Apr 09, 2008

RAMAT GAN, Israel--(BUSINESS WIRE)--Obecure Ltd., a clinical stage company focused on development of novel therapeutics for weight management, announced today the execution of a strategic manufacturing and supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group (Grunenthal).

Back to news